Understanding Parkinson's Disease through the Use of Cell Reprogramming
Rebecca Playne1, Bronwen Connor2
1Department of Pharmacology and Clinical Pharmacology, Centre for Brain Research, School of Medical Science, FMHS, University of Auckland, Auckland, 1023, New Zealand.
Stem Cell Reviews and Reports
|January 14, 2017
Summary
Direct reprogramming offers a faster, more efficient method for creating aged dopaminergic neuron models for Parkinson's disease (PD) research. Current protocols for generating authentic, mature ventral midbrain dopamine (vmDA) neurons via direct reprogramming are limited, highlighting a key research gap.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Regenerative Medicine
Background:
- Parkinson's disease (PD) is a complex neurodegenerative disorder influenced by aging, genetics, and environmental factors.
- Accurate cell-based models are crucial for understanding PD, ideally mimicking aged human dopaminergic neurons.
- Generating sufficient quantities of mature ventral midbrain dopamine (vmDA) neurons, especially aged ones, remains a significant challenge.
Purpose of the Study:
- To review current strategies for generating vmDA neurons for PD research.
- To explore the potential of direct reprogramming for modeling PD.
- To identify limitations and future directions in vmDA neuron generation.
Main Methods:
- Review of existing literature on somatic cell reprogramming techniques.
- Analysis of methods for generating vmDA neurons from induced pluripotent stem (iPS) cells.
- Evaluation of direct reprogramming strategies for neuronal differentiation.
Main Results:
- Induced pluripotent stem (iPS) cell technology has been widely used for PD modeling.
- Direct reprogramming is faster and more efficient than iPS cell reprogramming and may preserve age-related markers.
- Protocols for direct reprogramming of adult somatic cells into authentic, mature vmDA neurons are currently lacking.
Conclusions:
- Direct reprogramming presents a promising alternative for PD modeling, potentially overcoming limitations of iPS cells.
- Further development of direct reprogramming protocols is needed to generate authentic, aged vmDA neurons for studying Parkinson's disease.
- Optimized direct reprogramming strategies could significantly advance the study and treatment of PD.
Keywords:
Direct reprogrammingDisease modellingDopamine neuronsInduced neural stem cellsInduced neuronsInduced pluripotent stem cellsParkinson’s diseaseReprogrammingMore Related Videos
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
01:29Somatic to iPS Cell Reprogramming
2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:37Neural Regulation
43.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K